News Search Results
Nov 29, 2023, 10:01 ET Multimodal Imaging Market to Reach $7.9 Billion, Globally, by 2032 at 6.1% CAGR: Allied Market Research
Market by Technology (PET/CT Systems, PET/MR Systems, SPECT/CT Systems, and Others), Application, (Brain &Neurology, Cardiology, Oncology, Ophthalmology, and Others), and End User, (Hospitals, Diagnostic imaging centers, and others.): Global Opportunity Analysis and Industry Forecast, 2023-2032". According
More news about: Allied Market Research
Nov 29, 2023, 10:00 ET ReFocus Eye Health Expands its Partner Network in DC, PA, NJ, and CT
Health's commitment to amplifying world-class retina care in Philadelphia and beyond.Ophthalmology Physicians and Surgeons A full-service practice that offers a broad range of ophthalmic specialties, including comprehensive eye care,
More news about: ReFocus Eye Health
Nov 29, 2023, 08:00 ET MellingMedical to Deliver Acclaro's UltraClear Cold Fiber Laser Technology to Federal Health Facilities
(IHS) and the Center for Disease Control (CDC). MellingMedical provides access to innovative and cost-effective healthcare solutions in ophthalmology, optometry, dermatology, ENT/neurology and urology. To learn more, visit
More news about: MellingMedical
Nov 28, 2023, 10:00 ET U.S. News to Debut Best Ambulatory Surgery Centers in 2024
relevant measures to produce a composite rating for each of several key specialty areas: orthopedics & spine, gastroenterology, urology, and ophthalmology. CareJourney, the market leader in provider cost and quality data, is the data partner for the new ratings, which will allow consumers to
More news about: U.S. News & World Report, L.P.
Nov 28, 2023, 09:05 ET Stealth BioTherapeutics to Present at the 2023 Ophthalmology Innovation Source Summit
Ophthalmology Innovation Summit (OIS) taking place in San Diego, California on Saturday, December
More news about: Stealth BioTherapeutics Inc.
Nov 28, 2023, 06:45 ET Provident Healthcare Partners Advises East Coast Institute for Research in its Partnership with Gauge Capital
IV trial process and holds deep sponsor relationships across several indications including cardiovascular, dyslipidemia, diabetes, obesity, and ophthalmology. The transaction represents Gauge Capital's entrance into the clinical research site sector.
More news about: Provident Healthcare Partners LLC
Nov 27, 2023, 07:57 ET Study Finds Online Course Effectively Trains Health Workers to Detect Glaucoma
patients with more complicated cases that need their services." The study, funded by a Novartis independent grant program, eXcellence in Ophthalmology Vision Awards (
More news about: Orbis International
Nov 23, 2023, 19:38 ET China's First NDA for a KRAS G12C Inhibitor: Innovent Announces the National Medical Products Administration of China Has Accepted and Granted Priority Review Designation to the New Drug Application for IBI351
biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that the New Drug Application (NDA) for IBI351 (KRAS G12C inhibitor) has been accepted by the Center
More news about: Innovent Biologics